Earlier in 2024, IREDA’s board had approved raising a sum of ₹4,500 crore by selling shares to eligible institutions. Previous Post Persistent Systems shares surge 7% after Q3 results but analysts say positives priced in Next Post Strides Pharma shares rise 7% after announcing OneSource trading debut date on BSE, NSE Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment
